
Sign up to save your podcasts
Or
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-11741 / March 2025
3
11 ratings
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-11741 / March 2025
139 Listeners
28 Listeners
0 Listeners
85 Listeners
0 Listeners